{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:54:00Z","timestamp":1789876440439,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40123-025-01183-2","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:31:47Z","timestamp":1750667507000},"page":"1843-1853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multiwavelength Photobiomodulation Improves Multiple Aspects of Visual Function in Early-Stage Dry Age-Related Macular Degeneration"],"prefix":"10.1007","volume":"14","author":[{"given":"Cem","family":"K\u00fc\u00e7\u00fckerd\u00f6nmez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7402-6789","authenticated-orcid":false,"given":"Stephanie E.","family":"Tedford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"issue":"2","key":"1183_CR1","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/S2214-109X(13)70163-3","volume":"2","author":"JB Jonas","year":"2014","unstructured":"Jonas JB. Global prevalence of age-related macular degeneration. Lancet Glob Health. 2014;2(2):e65\u20136.","journal-title":"Lancet Glob Health"},{"issue":"12","key":"1183_CR2","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1001\/jamaophthalmol.2022.4401","volume":"140","author":"DB Rein","year":"2022","unstructured":"Rein DB, Wittenborn JS, Burke-Conte Z, et al. Prevalence of age-related macular degeneration in the US in 2019. JAMA Ophthalmol. 2022;140(12):1202\u20138.","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"1183_CR3","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.3390\/ijms23052592","volume":"23","author":"AR Fernandes","year":"2022","unstructured":"Fernandes AR, et al. Exudative versus nonexudative age-related macular degeneration: physiopathology and treatment options. Int J Mol Sci. 2022;23(5):2592. https:\/\/doi.org\/10.3390\/ijms23052592.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1183_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.mcna.2021.01.003","volume":"105","author":"CJ Thomas","year":"2021","unstructured":"Thomas CJ, Mirza RG, Gill MK. Age-related macular degeneration. Med Clin North Am. 2021;105(3):473\u201391.","journal-title":"Med Clin North Am"},{"issue":"11\u201312","key":"1183_CR5","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/jbio.201670113","volume":"9","author":"MR Hamblin","year":"2016","unstructured":"Hamblin MR. Photobiomodulation or low-level laser therapy. J Biophotonics. 2016;9(11\u201312):1122\u20134.","journal-title":"J Biophotonics"},{"key":"1183_CR6","first-page":"49","volume":"3","author":"JC Rojas","year":"2011","unstructured":"Rojas JC, Gonzalez-Lima F. Low-level light therapy of the eye and brain. Eye Brain. 2011;3:49\u201367.","journal-title":"Eye Brain"},{"issue":"2","key":"1183_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/php.12864","volume":"94","author":"MR Hamblin","year":"2018","unstructured":"Hamblin MR. Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochem Photobiol. 2018;94(2):199\u2013212.","journal-title":"Photochem Photobiol"},{"key":"1183_CR8","doi-asserted-by":"publisher","DOI":"10.1109\/JSTQE.2016.2561201","author":"LF de Freitas","year":"2016","unstructured":"de Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron. 2016;22(3). https:\/\/doi.org\/10.1109\/JSTQE.2016.2561201.","journal-title":"IEEE J Sel Top Quantum Electron"},{"issue":"3","key":"1183_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.freeradbiomed.2012.05.009","volume":"53","author":"M Mor\u00e1n","year":"2012","unstructured":"Mor\u00e1n M, Moreno-Lastres D, Mar\u00edn-Buera L, Arenas J, Mart\u00edn MA, Ugalde C. Mitochondrial respiratory chain dysfunction: implications in neurodegeneration. Free Radic Biol Med. 2012;53(3):595\u2013609. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.05.009.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"1183_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/cns.13116","volume":"25","author":"Y Wang","year":"2019","unstructured":"Wang Y, Xu E, Musich PR, Lin F. Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neurosci Ther. 2019;25(7):816\u201324. https:\/\/doi.org\/10.1111\/cns.13116.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"1183_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/IAE.0000000000003980","volume":"44","author":"D Boyer","year":"2024","unstructured":"Boyer D, Hu A, Warrow D, et al. LIGHTSITE III: 13-month efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative (dry) age-related macular degeneration using the LumiThera Valeda Light Delivery System. Retina. 2024;44(3):487\u201397. https:\/\/doi.org\/10.1097\/IAE.0000000000003980.","journal-title":"Retina"},{"issue":"8","key":"1183_CR12","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1097\/IAE.0000000000002632","volume":"40","author":"SN Markowitz","year":"2020","unstructured":"Markowitz SN, et al. A double-masked, randomized, sham-controlled, single-center study with photobiomodulation for the treatment of dry age-related macular degeneration. Retina. 2020;40(8):1471\u201382.","journal-title":"Retina"},{"key":"1183_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s40123-022-00640-6","volume":"12","author":"B Burton","year":"2023","unstructured":"Burton B, Parodi MB, J\u00fcrgens I, et al. LIGHTSITE II randomized multicenter trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration. Ophthalmol Ther. 2023;12:953\u201368. https:\/\/doi.org\/10.1007\/s40123-022-00640-6.","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"1183_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40123-022-00583-y","volume":"12","author":"T Leng","year":"2023","unstructured":"Leng T, Schwartz J, Nimke D, et al. Dry age-related macular degeneration: distribution of visual acuity and progression risk in a large registry. Ophthalmol Ther. 2023;12(1):325\u201340. https:\/\/doi.org\/10.1007\/s40123-022-00583-y.","journal-title":"Ophthalmol Ther"},{"key":"1183_CR15","doi-asserted-by":"publisher","first-page":"1388602","DOI":"10.3389\/fopht.2024.1388602","volume":"4","author":"K Valter","year":"2024","unstructured":"Valter K, Tedford SE, Eells JT, Tedford CE. Photobiomodulation use in ophthalmology\u2014an overview of translational research from bench to bedside. Front Ophthalmol (Lausanne). 2024;4:1388602. https:\/\/doi.org\/10.3389\/fopht.2024.1388602.","journal-title":"Front Ophthalmol (Lausanne)"},{"issue":"4","key":"1183_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/jnr.0000000000000309","volume":"27","author":"N Ozen","year":"2019","unstructured":"Ozen N, et al. Nonadherence in hemodialysis patients and related factors: a multicenter study. J Nurs Res. 2019;27(4):e36. https:\/\/doi.org\/10.1097\/jnr.0000000000000309.","journal-title":"J Nurs Res"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01183-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01183-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01183-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T02:27:00Z","timestamp":1776479220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01183-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1183"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01183-2","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Cem K\u00fc\u00e7\u00fckerd\u00f6nmez declares that he has no competing interests. Stephanie Tedford is an employee of LumiThera.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Written informed consent was obtained from all participants in this study prior to receiving treatment with Valeda. Consent allowed for data review and publication efforts. Institutional review board\/ethics committee approval was obtained from Netgoz Eye Hospital (Bayrakli, Izmir, Turkey). This study was conducted in compliance with the protocol, Good Clinical Practice guidelines, the guidelines of the Declaration of Helsinki and all other applicable regulatory requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}